Month: March 2020

Fourth Quarter 2019 Highlights (all comparisons are made to the prior year fourth quarter):Net Sales decreased 10.7% to $283.2MGross profit of 12.2%; adjusted gross profit of 21.5% decreased 250bpsEPS loss of $0.85; adjusted EPS of $0.40 decreased from $0.61 a year agoAdjusted EBITDA of $15.0M decreased 46.4%; adjusted EBITDA margin of 5.3% declined 350bps2019 Highlights (all comparisons are made to the prior year):Net sales were relatively flat; adjusted net sales decreased 7.8% to $1.15BGross profit of 21.1%; adjusted gross profit of 22.0% decreased 180bpsEPS of $0.95; adjusted EPS of $1.59 decreased from $2.94 a year agoAdjusted EBITDA of $68.3M decreased 41.3%; adjusted EBITDA margin of 5.9% declined 340bpsBegan restructuring initiatives related to strategic pillars for profitable growth – Simplify, Focus and GrowCHATTANOOGA, Tenn.,...

CALGARY, Alberta, March 03, 2020 (GLOBE NEWSWIRE) —  NuVista Energy Ltd. (“NuVista” or the “Company”) (TSX:NVA) is pleased to announce results for the three months and year ended December 31, 2019 and provide a number of updates which demonstrate continued successful advancement of our Pipestone and Wapiti Montney play development.Record 2019 Production and Adjusted Funds FlowDuring the quarter and year ended December 31, 2019, NuVista:Produced a record 57,010 Boe/d for the fourth quarter of 2019, or 16% greater than the respective quarter in 2018.  Full year 2019 production was a record 50,803 Boe/d, or 26% greater than 2018 production.  This represents annual production per weighted average share which was 6% greater than the prior year;Achieved $70.1 million adjusted funds flow in the quarter, including over $17 million of free...

DUBLIN, March 03, 2020 (GLOBE NEWSWIRE) — Coinciding with World Obesity Day, Medtronic further demonstrated its ongoing commitment to increasing patient access to quality care by taking the Pledge to Eradicate Weight Stigma. This action aligns with a joint consensus statement on the causes and negative consequences of obesity bias published today in Nature Medicine by a team of experts led by Professor Francesco Rubino from King’s College London.According to the World Health Organization, more than 650 million people worldwide are living with obesity, which is amplified by numerous factors, many of which are beyond an individual’s control. In supporting the pledge, Medtronic condemns the use of stigmatizing language, images, attitudes, policies, and weight-based discrimination, wherever they occur, and commits to: Treat individuals...

TORONTO, March 03, 2020 (GLOBE NEWSWIRE) — BE Resources Inc. (TSXV: BER.H) (“BE Resources” or the “Company”) announces that it has reached an agreement (the “Debt Settlement”) with Keyser Soze Services Limited (the “Support Creditor”) to settle an aggregate of $87,692.55 in debt owed by the Company to the Support Creditor in respect of short-term operational loans made to the Company by the Support Creditor to pay invoices of the Company for services rendered from June 2019 to December 2019. The Support Creditor has agreed to convert its collective indebtedness into common shares of the Company (“Common Shares”) at a price of $0.12 per Common Share, subject to receipt of the approval from the TSX Venture Exchange. It is expected that, upon the completion of the Debt settlement, subject to receipt of the requisite approvals, the...

NEWTON, Mass., March 03, 2020 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), an oncology-focused pharmaceutical company, today announced the pricing of its previously announced registered underwritten public offering of 6,250,000 shares of its common stock  at a price to the public of $24.00 per share. The gross proceeds to Karyopharm from the offering, before deducting the underwriting discounts and commissions and other estimated offering expenses, are expected to be $150.0 million. The offering is expected to close on or about March 6, 2020, subject to customary closing conditions. In addition, Karyopharm has granted the underwriters a 30-day option to purchase up to 937,500 additional shares of its common stock.Karyopharm intends to use the net proceeds of the offering (i) to maintain and grow the infrastructure...

The Monterrey (+12.4%), Culiacán (+11.4%), and Mazatlán (+19.3%) airports contributed most to traffic growthMEXICO CITY, March 03, 2020 (GLOBE NEWSWIRE) — Mexican airport operator Grupo Aeroportuario del Centro Norte, S.A.B. de C.V., known as OMA (NASDAQ: OMAB; BMV: OMA), reports that terminal passenger traffic at its 13 airports increased 12.7% in February 2020, as compared to February 2019. Domestic traffic increased 12.6%, and international traffic increased 13.5%.During February 2020, domestic traffic increased in all of our airports, with the largest increases in:Monterrey (+11.6%) as a result of increased traffic on the Mexico City route.Culiacán (+11.3%) benefitted from increased traffic on the Mexico City and Tijuana routes.Mazatlán (+27.4%) benefitted from increased traffic on the Tijuana route.Chihuahua (+14.4%), due to...

TORONTO, March 03, 2020 (GLOBE NEWSWIRE) — Canadian Orebodies Inc. (the “Company”) (TSXV:CORE) is pleased to announce that it has closed the non-brokered private placements (the “Financing”) that were previously announced on January 10, 2020 and February 13, 2020. The Company raised aggregate gross proceeds of $1,174,000 through the sale of 4,920,000 common shares (the “Shares”) at a price of $0.10 per Share, 850,000 flow-through common shares (the “FT Shares”) at a price of $0.12 per FT Share, and 4,000,000 flow-through common shares (the “Premium FT Shares”) at a price of $0.145 per Premium FT Share.“We would like to thank all our shareholders for their continued support, and in particular Northfield Capital Corporation and O3 Mining Inc. for their backing in this financing. We were pleased to raise more than our initial goal...

バミューダ諸島ハミルトン発 , March 04, 2020 (GLOBE NEWSWIRE) — エンスター･グループ･リミテッド (Enstar Group Limited、NASDAQ: ESGR) は本日、完全子会社の1社がアスペン保険ホールディングス･リミテッド (Aspen Insurance Holdings Limited) とアドバース･ディベロップメント･カバー再保険契約を締結したと発表した。この取引では、米国、英国、ヨーロッパの多様な資産、負債、専門ラインで2019年12月31日以前に発生した損失に対して、7億7,000万ドル (約831億6,000万円) の保険料でエンスター子会社が再保険をかける。  エンスターは、損害保有額38億500万ドル (約4,109億4,000万円) 超過時の保険料7億7,000万ドル (約831億6,000万円) のほか、48億1,500万ドル (約5,200億2,000万円) 超過時の追加保険料2億5,000万ドル (約270億円) を提供する。 取引完了には、規制当局の承認を受けることや、その他各種の完了条件を満たすことが必要である。この取引は2020年上期に成立が見込まれる。エンスターについてエンスター (Enstar) は、バミューダ諸島、米国、英国、欧州大陸、オーストラリア、その他の国際拠点にあるグループ企業のネットワークを通じて画期的な資本リリースソリューションや特殊アンダーライティング能力を提供する、多角的保険グループである。2001年の創業以来、100社ほどの企業やポートフォリオを買収してきた実績を持つ、レガシー買収のマーケットリーダーである。同グループの現行のアンダーライティング事業には、グローバルなアンダーライティングプラットフォームを複数備えたAクラスの世界的な特殊保険企業グループであるスターストーン (StarStone)、ロイズ (Lloyd’s) のシンジケート609...

TULSA, March 03, 2020 (GLOBE NEWSWIRE) — Mid-Con Energy Partners, LP (NASDAQ: MCEP) (“Mid-Con” or the “Partnership”) announces that the Board of Directors of its General Partner has approved a 1-for-10 reverse split on its common units, effective after the market closes on March 23, 2020.Pursuant to the reverse unit split, common unitholders will receive one common unit for every ten common units owned at the close of business on March 23, 2020.  All fractional units created by the reverse unit split will be rounded to the nearest whole unit, as provided by Mid-Con’s partnership agreement.  If the fraction created is less than one-half, it will be rounded down to the nearest whole unit.  If the fraction is one-half or more, it will be rounded up to the nearest whole unit.  The Partnership anticipates that the reverse split will...

MEDFORD, March 03, 2020 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, announced today that it will release financial results for the fourth quarter and full year 2019 after the close of trading on Thursday, March 12, 2020.The company’s management team will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing 877-407-0778 from the US or 201-689-8565 from outside the US or by accessing www.chembio.com/investors/calendar-of-events/. A replay of the call will be available by dialing 877-481-4010 from the US or 919-882-2331 from outside the US (using passcode 33460) or by accessing www.chembio.com/investors/calendar-of-events/.About Chembio DiagnosticsChembio...